Citius Pharmaceuticals, Inc. financial data

Symbol
CTXR on Nasdaq
Location
11 Commerce Drive, 1 St Floor, Cranford, NJ
State of incorporation
NV
Fiscal year end
September 30
Former names
Trail One, Inc. (to 9/18/2014), TrailOne, Inc. (to 1/21/2011)
Latest financial report
10-K - Q3 2024 - Dec 27, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 185 % -73%
Debt-to-equity 23.8 % +91.1%
Return On Equity -44.7 % -44%
Return On Assets -39.4 % -41.8%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 7.73M shares -95.1%
Common Stock, Shares, Outstanding 7.25M shares +14.1%
Entity Public Float 157M USD -34.6%
Common Stock, Value, Issued 7.25K USD +14.1%
Weighted Average Number of Shares Outstanding, Basic 6.73M shares +11.2%
Weighted Average Number of Shares Outstanding, Diluted 6.73M shares +11.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 11.9M USD -19.7%
General and Administrative Expense 18.2M USD +19.3%
Operating Income (Loss) -42M USD -14.3%
Nonoperating Income (Expense) 3.15M USD -34%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -38.8M USD -21.5%
Income Tax Expense (Benefit) 576K USD 0%
Net Income (Loss) Attributable to Parent -38.3M USD -25.2%
Earnings Per Share, Basic -5.57 USD/shares -2322%
Earnings Per Share, Diluted -5.57 USD/shares -2322%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 3.25M USD -87.7%
Assets, Current 14.2M USD -58.6%
Property, Plant and Equipment, Net 275 USD -89.6%
Operating Lease, Right-of-Use Asset 246K USD -45.8%
Goodwill 9.35M USD 0%
Other Assets, Noncurrent 102M USD +48.6%
Assets 117M USD +12.6%
Accounts Payable, Current 4.93M USD +68.3%
Employee-related Liabilities, Current 2.23M USD +3.34%
Accrued Liabilities, Current 17K USD -96.4%
Liabilities, Current 35.8M USD +520%
Deferred Income Tax Liabilities, Net 6.71M USD +9.38%
Operating Lease, Liability, Noncurrent 21.3K USD -91.9%
Liabilities 42.5M USD +249%
Retained Earnings (Accumulated Deficit) -201M USD -24.1%
Stockholders' Equity Attributable to Parent 70.1M USD -22.8%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 74.1M USD -19%
Liabilities and Equity 117M USD +12.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.14M USD -27.2%
Common Stock, Shares Authorized 16M shares 0%
Common Stock, Shares, Issued 7.25M shares +14.1%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 3.25M USD -87.7%
Deferred Tax Assets, Valuation Allowance 53.8M USD +19.8%
Operating Lease, Liability 263K USD -45.4%
Depreciation 578 USD -20.8%
Lessee, Operating Lease, Liability, to be Paid 275K USD -47.5%
Operating Lease, Liability, Current 242K USD +10.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 21.5K USD -91.5%
Lessee, Operating Lease, Liability, to be Paid, Year One 254K USD +1.95%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Deferred Income Tax Expense (Benefit) 144K USD 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 12.5K USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 21.5K USD
Deferred Tax Assets, Operating Loss Carryforwards 39.9M USD +14%
Preferred Stock, Shares Authorized 10M shares 0%
Additional Paid in Capital 271M USD +7.27%
Share-based Payment Arrangement, Expense 11.8M USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%